A single-arm clinical study of the efficacy, security, and pharmacokinetics of Paxlovid in hemodialysis patients with covid-19
Published: 6 February 2023| Version 1 | DOI: 10.17632/374kbn4bhb.1
In Huashan Hospital Affiliated with Fudan University, 29 patients were included in the Paxlovid group and 57 patients in the non-Paxlovid group. Irrespective of whether the methodology is established or not, the study time was divided into two stages: stage 1, lying before April 29th and stage 2, lying after April 29th. Data were collected to determine the Paxlovid efficacy and the security.